| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | glucuronosyltransferase activity | 2.11e-06 | 35 | 121 | 5 | GO:0015020 | |
| GeneOntologyMolecularFunction | ATP:ADP antiporter activity | 2.15e-06 | 5 | 121 | 3 | GO:0005471 | |
| GeneOntologyMolecularFunction | retinoic acid binding | 2.35e-05 | 28 | 121 | 4 | GO:0001972 | |
| GeneOntologyMolecularFunction | ADP transmembrane transporter activity | 3.46e-05 | 11 | 121 | 3 | GO:0015217 | |
| GeneOntologyMolecularFunction | ATP transmembrane transporter activity | 7.52e-05 | 14 | 121 | 3 | GO:0005347 | |
| GeneOntologyMolecularFunction | retinoid binding | 2.03e-04 | 48 | 121 | 4 | GO:0005501 | |
| GeneOntologyMolecularFunction | isoprenoid binding | 2.20e-04 | 49 | 121 | 4 | GO:0019840 | |
| GeneOntologyMolecularFunction | UDP-glycosyltransferase activity | 3.42e-04 | 153 | 121 | 6 | GO:0008194 | |
| GeneOntologyMolecularFunction | purine ribonucleotide transmembrane transporter activity | 3.52e-04 | 23 | 121 | 3 | GO:0005346 | |
| GeneOntologyMolecularFunction | adenine transmembrane transporter activity | 3.60e-04 | 5 | 121 | 2 | GO:0015207 | |
| GeneOntologyMolecularFunction | oxidative phosphorylation uncoupler activity | 3.60e-04 | 5 | 121 | 2 | GO:0017077 | |
| GeneOntologyMolecularFunction | adenine nucleotide transmembrane transporter activity | 5.10e-04 | 26 | 121 | 3 | GO:0000295 | |
| GeneOntologyMolecularFunction | protein kinase C binding | 6.92e-04 | 66 | 121 | 4 | GO:0005080 | |
| GeneOntologyMolecularFunction | purine nucleotide transmembrane transporter activity | 7.07e-04 | 29 | 121 | 3 | GO:0015216 | |
| GeneOntologyMolecularFunction | fatty acid binding | 8.18e-04 | 69 | 121 | 4 | GO:0005504 | |
| GeneOntologyMolecularFunction | acyltransferase activity | NAA15 MOGAT2 DTL PORCN MDM4 TRIM59 FANCF TMEM129 RNF123 ATG3 TRIM56 EPB42 NAA16 | 8.49e-04 | 775 | 121 | 13 | GO:0016746 |
| GeneOntologyMolecularFunction | nucleotide transmembrane transporter activity | 1.04e-03 | 33 | 121 | 3 | GO:0015215 | |
| GeneOntologyMolecularFunction | steroid binding | 1.30e-03 | 133 | 121 | 5 | GO:0005496 | |
| GeneOntologyMolecularFunction | purine nucleobase transmembrane transporter activity | 1.59e-03 | 10 | 121 | 2 | GO:0005345 | |
| GeneOntologyMolecularFunction | organophosphate ester transmembrane transporter activity | 1.69e-03 | 39 | 121 | 3 | GO:0015605 | |
| GeneOntologyMolecularFunction | hexosyltransferase activity | 1.82e-03 | 211 | 121 | 6 | GO:0016758 | |
| GeneOntologyMolecularFunction | nucleobase transmembrane transporter activity | 1.93e-03 | 11 | 121 | 2 | GO:0015205 | |
| GeneOntologyBiologicalProcess | estrogen catabolic process | 4.90e-09 | 5 | 117 | 4 | GO:0006711 | |
| GeneOntologyBiologicalProcess | glucuronate metabolic process | 6.14e-09 | 26 | 117 | 6 | GO:0019585 | |
| GeneOntologyBiologicalProcess | uronic acid metabolic process | 6.14e-09 | 26 | 117 | 6 | GO:0006063 | |
| GeneOntologyBiologicalProcess | phenylpropanoid catabolic process | 1.46e-08 | 6 | 117 | 4 | GO:0046271 | |
| GeneOntologyBiologicalProcess | coumarin catabolic process | 1.46e-08 | 6 | 117 | 4 | GO:0046226 | |
| GeneOntologyBiologicalProcess | flavone metabolic process | 1.46e-08 | 6 | 117 | 4 | GO:0051552 | |
| GeneOntologyBiologicalProcess | cellular glucuronidation | 1.02e-07 | 21 | 117 | 5 | GO:0052695 | |
| GeneOntologyBiologicalProcess | phenylpropanoid metabolic process | 2.01e-07 | 10 | 117 | 4 | GO:0009698 | |
| GeneOntologyBiologicalProcess | coumarin metabolic process | 2.01e-07 | 10 | 117 | 4 | GO:0009804 | |
| GeneOntologyBiologicalProcess | flavonoid metabolic process | 6.76e-07 | 13 | 117 | 4 | GO:0009812 | |
| GeneOntologyBiologicalProcess | flavonoid glucuronidation | 1.76e-06 | 5 | 117 | 3 | GO:0052696 | |
| GeneOntologyBiologicalProcess | mitochondrial ADP transmembrane transport | 1.76e-06 | 5 | 117 | 3 | GO:0140021 | |
| GeneOntologyBiologicalProcess | secondary metabolic process | 2.20e-06 | 67 | 117 | 6 | GO:0019748 | |
| GeneOntologyBiologicalProcess | hormone catabolic process | 5.46e-06 | 21 | 117 | 4 | GO:0042447 | |
| GeneOntologyBiologicalProcess | mitochondrial ATP transmembrane transport | 9.76e-06 | 8 | 117 | 3 | GO:1990544 | |
| GeneOntologyBiologicalProcess | estrogen metabolic process | 1.13e-05 | 52 | 117 | 5 | GO:0008210 | |
| GeneOntologyBiologicalProcess | hormone metabolic process | 3.73e-05 | 286 | 117 | 9 | GO:0042445 | |
| GeneOntologyBiologicalProcess | xenobiotic glucuronidation | 3.77e-05 | 12 | 117 | 3 | GO:0052697 | |
| GeneOntologyBiologicalProcess | ADP transport | 3.77e-05 | 12 | 117 | 3 | GO:0015866 | |
| GeneOntologyBiologicalProcess | steroid catabolic process | 4.00e-05 | 34 | 117 | 4 | GO:0006706 | |
| GeneOntologyBiologicalProcess | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway | 7.70e-05 | 15 | 117 | 3 | GO:1901029 | |
| GeneOntologyBiologicalProcess | pigment metabolic process | 1.98e-04 | 94 | 117 | 5 | GO:0042440 | |
| GeneOntologyBiologicalProcess | negative regulation of mitochondrial membrane permeability | 2.90e-04 | 23 | 117 | 3 | GO:0035795 | |
| GeneOntologyBiologicalProcess | ATP transport | 2.90e-04 | 23 | 117 | 3 | GO:0015867 | |
| GeneOntologyBiologicalProcess | regulation of branching involved in mammary gland duct morphogenesis | 3.15e-04 | 5 | 117 | 2 | GO:0060762 | |
| GeneOntologyBiologicalProcess | regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway | 3.30e-04 | 24 | 117 | 3 | GO:1901028 | |
| GeneOntologyBiologicalProcess | heart development | EEF1AKMT4-ECE2 TMEM67 NRAP SLC25A4 RPS6KA2 ITGA4 MDM4 TGFB1 SLIT2 IGF1R COL14A1 FLRT3 CPLANE1 | 3.65e-04 | 757 | 117 | 13 | GO:0007507 |
| GeneOntologyBiologicalProcess | negative regulation of membrane permeability | 4.20e-04 | 26 | 117 | 3 | GO:1905709 | |
| GeneOntologyBiologicalProcess | adenine transport | 4.71e-04 | 6 | 117 | 2 | GO:0015853 | |
| Domain | UDPGT | 1.81e-07 | 21 | 119 | 5 | PF00201 | |
| Domain | UDPGT | 1.81e-07 | 21 | 119 | 5 | PS00375 | |
| Domain | UDP_glucos_trans | 1.81e-07 | 21 | 119 | 5 | IPR002213 | |
| Domain | fn3 | 9.35e-06 | 162 | 119 | 8 | PF00041 | |
| Domain | FN3 | 2.45e-05 | 185 | 119 | 8 | SM00060 | |
| Domain | NatA_aux_su | 4.03e-05 | 2 | 119 | 2 | IPR021183 | |
| Domain | NARP1 | 4.03e-05 | 2 | 119 | 2 | PF12569 | |
| Domain | FN3 | 4.12e-05 | 199 | 119 | 8 | PS50853 | |
| Domain | Mit_uncoupling | 5.32e-05 | 12 | 119 | 3 | IPR002030 | |
| Domain | FN3_dom | 5.83e-05 | 209 | 119 | 8 | IPR003961 | |
| Domain | ETS_PEA3_N | 1.20e-04 | 3 | 119 | 2 | IPR006715 | |
| Domain | ETS_PEA3_N | 1.20e-04 | 3 | 119 | 2 | PF04621 | |
| Domain | Aden_trnslctor | 7.35e-04 | 28 | 119 | 3 | IPR002113 | |
| Pathway | REACTOME_GLUCURONIDATION | 3.27e-07 | 24 | 88 | 5 | MM14599 | |
| Pathway | REACTOME_ASPIRIN_ADME | 3.34e-07 | 45 | 88 | 6 | MM15694 | |
| Pathway | REACTOME_GLUCURONIDATION | 4.07e-07 | 25 | 88 | 5 | M17787 | |
| Pathway | WP_GLUCURONIDATION | 4.07e-07 | 25 | 88 | 5 | MM15820 | |
| Pathway | KEGG_ASCORBATE_AND_ALDARATE_METABOLISM | 4.07e-07 | 25 | 88 | 5 | M605 | |
| Pathway | WP_GLUCURONIDATION | 5.01e-07 | 26 | 88 | 5 | M39404 | |
| Pathway | KEGG_PENTOSE_AND_GLUCURONATE_INTERCONVERSIONS | 7.42e-07 | 28 | 88 | 5 | M19580 | |
| Pathway | KEGG_PORPHYRIN_AND_CHLOROPHYLL_METABOLISM | 5.31e-06 | 41 | 88 | 5 | M7399 | |
| Pathway | REACTOME_ASPIRIN_ADME | 7.58e-06 | 44 | 88 | 5 | M45014 | |
| Pathway | WP_ESTROGEN_METABOLISM | 9.52e-06 | 22 | 88 | 4 | MM15888 | |
| Pathway | KEGG_DRUG_METABOLISM_OTHER_ENZYMES | 1.58e-05 | 51 | 88 | 5 | M17726 | |
| Pathway | KEGG_STARCH_AND_SUCROSE_METABOLISM | 1.74e-05 | 52 | 88 | 5 | M14171 | |
| Pathway | KEGG_STEROID_HORMONE_BIOSYNTHESIS | 2.30e-05 | 55 | 88 | 5 | M14933 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_VGCC_CA2_APOPTOTIC_PATHWAY_N01006 | 2.73e-05 | 10 | 88 | 3 | M47694 | |
| Pathway | WP_METAPATHWAY_BIOTRANSFORMATION | 4.70e-05 | 153 | 88 | 7 | MM15844 | |
| Pathway | KEGG_RETINOL_METABOLISM | 4.82e-05 | 64 | 88 | 5 | M9488 | |
| Pathway | REACTOME_TRANSPORT_OF_NUCLEOSIDES_AND_FREE_PURINE_AND_PYRIMIDINE_BASES_ACROSS_THE_PLASMA_MEMBRANE | 4.97e-05 | 12 | 88 | 3 | M27728 | |
| Pathway | WP_IRINOTECAN_PATHWAY | 4.97e-05 | 12 | 88 | 3 | M39611 | |
| Pathway | REACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS | 5.43e-05 | 107 | 88 | 6 | MM14595 | |
| Pathway | REACTOME_DRUG_ADME | 6.03e-05 | 109 | 88 | 6 | M45012 | |
| Pathway | REACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS | 6.03e-05 | 109 | 88 | 6 | M18788 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_PSEN1_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 6.43e-05 | 13 | 88 | 3 | M47696 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_SIGMAR1_TO_CA2_APOPTOTIC_PATHWAY | 6.43e-05 | 13 | 88 | 3 | M47751 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SNCA_TO_VGCC_CA2_APOPTOTIC_PATHWAY | 6.43e-05 | 13 | 88 | 3 | M47703 | |
| Pathway | KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450 | 7.43e-05 | 70 | 88 | 5 | M16794 | |
| Pathway | WP_CODEINE_AND_MORPHINE_METABOLISM | 8.14e-05 | 14 | 88 | 3 | M39328 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_VGCC_CA2_APOPTOTIC_PATHWAY_N01004 | 8.14e-05 | 14 | 88 | 3 | M47692 | |
| Pathway | KEGG_DRUG_METABOLISM_CYTOCHROME_P450 | 8.51e-05 | 72 | 88 | 5 | M9257 | |
| Pathway | REACTOME_DRUG_ADME | 9.83e-05 | 119 | 88 | 6 | MM15692 | |
| Pathway | REACTOME_PARACETAMOL_ADME | 9.87e-05 | 39 | 88 | 4 | MM15695 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_TRANSPORT_OF_CALCIUM | 1.01e-04 | 15 | 88 | 3 | M47691 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_PSEN_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 1.24e-04 | 16 | 88 | 3 | M47695 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABBERANT_ATXN2_3_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 1.79e-04 | 18 | 88 | 3 | M47659 | |
| Pathway | KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_TRANSPORT_OF_CALCIUM | 1.79e-04 | 18 | 88 | 3 | M47761 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_TRANSPORT_OF_CALCIUM | 2.12e-04 | 19 | 88 | 3 | M47677 | |
| Pathway | KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 2.12e-04 | 19 | 88 | 3 | M47760 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MACHR_CA2_APOPTOTIC_PATHWAY | 2.48e-04 | 20 | 88 | 3 | M47688 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_MACHR_CA2_APOPTOTIC_PATHWAY | 2.88e-04 | 21 | 88 | 3 | M47689 | |
| Pathway | WP_2Q37_COPY_NUMBER_VARIATION_SYNDROME | 2.89e-04 | 145 | 88 | 6 | M45512 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 3.32e-04 | 22 | 88 | 3 | M47690 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MGLUR5_CA2_APOPTOTIC_PATHWAY | 3.32e-04 | 22 | 88 | 3 | M47675 | |
| Pathway | KEGG_MEDICUS_REFERENCE_VGCC_CA2_APOPTOTIC_PATHWAY | 3.80e-04 | 23 | 88 | 3 | M47666 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 3.80e-04 | 23 | 88 | 3 | M47676 | |
| Pathway | WP_ELECTRON_TRANSPORT_CHAIN_OXPHOS_SYSTEM_IN_MITOCHONDRIA | 5.00e-04 | 105 | 88 | 5 | M39417 | |
| Pathway | WP_METAPATHWAY_BIOTRANSFORMATION_PHASE_I_AND_II | 9.90e-04 | 183 | 88 | 6 | M39588 | |
| Pathway | KEGG_PARKINSONS_DISEASE | 1.31e-03 | 130 | 88 | 5 | M7272 | |
| Pathway | REACTOME_INTERACTIONS_OF_VPR_WITH_HOST_CELLULAR_PROTEINS | 1.57e-03 | 37 | 88 | 3 | M1029 | |
| Pathway | BIOCARTA_ETC_PATHWAY | 1.68e-03 | 10 | 88 | 2 | M15371 | |
| Pathway | REACTOME_TRANSPORT_OF_NUCLEOSIDES_AND_FREE_PURINE_AND_PYRIMIDINE_BASES_ACROSS_THE_PLASMA_MEMBRANE | 2.04e-03 | 11 | 88 | 2 | MM15471 | |
| Pathway | REACTOME_TRANSPORT_OF_VITAMINS_NUCLEOSIDES_AND_RELATED_MOLECULES | 2.42e-03 | 43 | 88 | 3 | M881 | |
| Pathway | REACTOME_BIOLOGICAL_OXIDATIONS | 2.47e-03 | 219 | 88 | 6 | MM14838 | |
| Pathway | REACTOME_BIOLOGICAL_OXIDATIONS | 2.52e-03 | 220 | 88 | 6 | M10320 | |
| Pubmed | 2.15e-09 | 6 | 122 | 4 | 32527940 | ||
| Pubmed | 2.15e-09 | 6 | 122 | 4 | 20297805 | ||
| Pubmed | Assignment of the human UDP glucuronosyltransferase gene (UGT1A1) to chromosome region 2q37. | 5.00e-09 | 7 | 122 | 4 | 8467709 | |
| Pubmed | 5.00e-09 | 7 | 122 | 4 | 8464825 | ||
| Pubmed | 5.00e-09 | 7 | 122 | 4 | 27514509 | ||
| Pubmed | 9.98e-09 | 8 | 122 | 4 | 20610558 | ||
| Pubmed | 9.98e-09 | 8 | 122 | 4 | 18052087 | ||
| Pubmed | 9.98e-09 | 8 | 122 | 4 | 17179145 | ||
| Pubmed | 1.79e-08 | 9 | 122 | 4 | 22511988 | ||
| Pubmed | Family-based genome-wide association scan of attention-deficit/hyperactivity disorder. | 1.79e-08 | 9 | 122 | 4 | 20732626 | |
| Pubmed | 2.98e-08 | 10 | 122 | 4 | 23642732 | ||
| Pubmed | 2.98e-08 | 10 | 122 | 4 | 11465080 | ||
| Pubmed | 2.98e-08 | 10 | 122 | 4 | 23371916 | ||
| Pubmed | A genome-wide association study of total bilirubin and cholelithiasis risk in sickle cell anemia. | 2.98e-08 | 10 | 122 | 4 | 22558097 | |
| Pubmed | 4.21e-08 | 3 | 122 | 3 | 12450408 | ||
| Pubmed | DNA sequences of two expressed nuclear genes for human mitochondrial ADP/ATP translocase. | 4.21e-08 | 3 | 122 | 3 | 2541251 | |
| Pubmed | Two distinct genes for ADP/ATP translocase are expressed at the mRNA level in adult human liver. | 4.21e-08 | 3 | 122 | 3 | 2829183 | |
| Pubmed | 4.21e-08 | 3 | 122 | 3 | 12847094 | ||
| Pubmed | 4.21e-08 | 3 | 122 | 3 | 29519853 | ||
| Pubmed | Role of UDP-glucuronosyltransferase isoforms in 13-cis retinoic acid metabolism in humans. | 6.98e-08 | 12 | 122 | 4 | 20308471 | |
| Pubmed | 6.98e-08 | 12 | 122 | 4 | 19419973 | ||
| Pubmed | Thirteen UDPglucuronosyltransferase genes are encoded at the human UGT1 gene complex locus. | 6.98e-08 | 12 | 122 | 4 | 11434514 | |
| Pubmed | UGT1A1 is a major locus influencing bilirubin levels in African Americans. | 1.01e-07 | 13 | 122 | 4 | 22085899 | |
| Pubmed | Genome-wide analysis of hepatic lipid content in extreme obesity. | 1.01e-07 | 13 | 122 | 4 | 25246029 | |
| Pubmed | 1.40e-07 | 14 | 122 | 4 | 21646302 | ||
| Pubmed | Human UDP-glucuronosyltransferases: metabolism, expression, and disease. | 1.40e-07 | 14 | 122 | 4 | 10836148 | |
| Pubmed | 1.40e-07 | 14 | 122 | 4 | 9295054 | ||
| Pubmed | Multiple variable first exons: a mechanism for cell- and tissue-specific gene regulation. | 1.40e-07 | 14 | 122 | 4 | 14672974 | |
| Pubmed | 1.68e-07 | 4 | 122 | 3 | 33396658 | ||
| Pubmed | 1.68e-07 | 4 | 122 | 3 | 17558305 | ||
| Pubmed | Genome-wide association meta-analysis for total serum bilirubin levels. | 2.54e-07 | 16 | 122 | 4 | 19414484 | |
| Pubmed | 2.76e-07 | 251 | 122 | 9 | 29031500 | ||
| Pubmed | Genome-wide association of serum bilirubin levels in Korean population. | 3.31e-07 | 17 | 122 | 4 | 20639394 | |
| Pubmed | 4.19e-07 | 5 | 122 | 3 | 20565459 | ||
| Pubmed | 4.19e-07 | 5 | 122 | 3 | 15057901 | ||
| Pubmed | 4.25e-07 | 18 | 122 | 4 | 20056724 | ||
| Pubmed | A genome-wide assessment of variability in human serum metabolism. | 5.36e-07 | 19 | 122 | 4 | 23281178 | |
| Pubmed | 8.36e-07 | 6 | 122 | 3 | 10620603 | ||
| Pubmed | Genetic determinants influencing human serum metabolome among African Americans. | 1.45e-06 | 24 | 122 | 4 | 24625756 | |
| Pubmed | 1.46e-06 | 7 | 122 | 3 | 21370995 | ||
| Pubmed | 2.33e-06 | 8 | 122 | 3 | 27641616 | ||
| Pubmed | 6.81e-06 | 11 | 122 | 3 | 18695635 | ||
| Pubmed | 9.05e-06 | 12 | 122 | 3 | 16120388 | ||
| Pubmed | Klotho suppresses tumor progression via inhibiting IGF-1R signaling in T‑cell lymphoma. | 1.22e-05 | 2 | 122 | 2 | 28656297 | |
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 21209102 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 26842067 | ||
| Pubmed | The ADP/ATP translocator is not essential for the mitochondrial permeability transition pore. | 1.22e-05 | 2 | 122 | 2 | 14749836 | |
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 11677206 | ||
| Pubmed | Studies on the substrate specificity of human intestinal UDP- lucuronosyltransferases 1A8 and 1A10. | 1.22e-05 | 2 | 122 | 2 | 10497143 | |
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 12944498 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 17529886 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 17624411 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 12112115 | ||
| Pubmed | Role of adenine nucleotide translocator 1 in mtDNA maintenance. | 1.22e-05 | 2 | 122 | 2 | 10926541 | |
| Pubmed | ETV5 transcriptionally activates TGFβ1 and promotes cancer cell invasion and migration of NSCLC. | 1.22e-05 | 2 | 122 | 2 | 37656259 | |
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 25547628 | ||
| Pubmed | The axis of local cardiac endogenous Klotho-TGF-β1-Wnt signaling mediates cardiac fibrosis in human. | 1.22e-05 | 2 | 122 | 2 | 31520610 | |
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 11901093 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 27048932 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 31325434 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 16556444 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 22031623 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 2823266 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 18568343 | ||
| Pubmed | Human UGT1A8 and UGT1A10 mRNA are expressed in primary human hepatocytes. | 1.22e-05 | 2 | 122 | 2 | 17603215 | |
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 15709193 | ||
| Pubmed | Expression and sequence analysis of the mouse adenine nucleotide translocase 1 and 2 genes. | 1.22e-05 | 2 | 122 | 2 | 10974536 | |
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 9647757 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 20089735 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 34204432 | ||
| Pubmed | A novel missense adenine nucleotide translocator-1 gene mutation in a Greek adPEO family. | 1.22e-05 | 2 | 122 | 2 | 11756613 | |
| Pubmed | SUMOylation of DDX39A Alters Binding and Export of Antiviral Transcripts to Control Innate Immunity. | IL12RB2 FAM234B TNFRSF25 NDUFB4 ZNF250 LRRTM4 SYT14 COL14A1 FLRT3 DNAH6 SERTAD3 NAA16 PSD4 | 2.08e-05 | 915 | 122 | 13 | 32393512 |
| Pubmed | 2.28e-05 | 16 | 122 | 3 | 20972438 | ||
| Pubmed | ETV1, 4 and 5: an oncogenic subfamily of ETS transcription factors. | 3.65e-05 | 3 | 122 | 2 | 22425584 | |
| Pubmed | 3.65e-05 | 3 | 122 | 2 | 12871699 | ||
| Pubmed | 3.65e-05 | 3 | 122 | 2 | 25203299 | ||
| Pubmed | 3.65e-05 | 3 | 122 | 2 | 26663878 | ||
| Pubmed | 3.65e-05 | 3 | 122 | 2 | 16636344 | ||
| Pubmed | Glucuronidation of psilocin and 4-hydroxyindole by the human UDP-glucuronosyltransferases. | 3.65e-05 | 3 | 122 | 2 | 20007669 | |
| Pubmed | 3.65e-05 | 3 | 122 | 2 | 19244109 | ||
| Pubmed | MicroRNA-34a Promotes Renal Fibrosis by Downregulation of Klotho in Tubular Epithelial Cells. | 3.65e-05 | 3 | 122 | 2 | 30853453 | |
| Pubmed | 3.65e-05 | 3 | 122 | 2 | 19225446 | ||
| Pubmed | TGF-β-induced expression of IGFBP-3 regulates IGF1R signaling in human osteosarcoma cells. | 3.65e-05 | 3 | 122 | 2 | 23831640 | |
| Pubmed | 3.65e-05 | 3 | 122 | 2 | 30149392 | ||
| Pubmed | Role of fibroblast growth factor 23 and klotho cross talk in idiopathic pulmonary fibrosis. | 3.65e-05 | 3 | 122 | 2 | 31042083 | |
| Pubmed | 3.65e-05 | 3 | 122 | 2 | 17406868 | ||
| Pubmed | 3.65e-05 | 3 | 122 | 2 | 23892434 | ||
| Pubmed | 3.65e-05 | 3 | 122 | 2 | 19996319 | ||
| Pubmed | 3.65e-05 | 3 | 122 | 2 | 9285689 | ||
| Pubmed | Identification of novel predictive markers for the prognosis of pancreatic ductal adenocarcinoma. | 3.65e-05 | 3 | 122 | 2 | 24745611 | |
| Pubmed | 3.65e-05 | 3 | 122 | 2 | 19364970 | ||
| Pubmed | The role of Pea3 group transcription factors in esophageal squamous cell carcinoma. | 3.65e-05 | 3 | 122 | 2 | 21689625 | |
| Pubmed | 3.65e-05 | 3 | 122 | 2 | 31160676 | ||
| Pubmed | 3.65e-05 | 3 | 122 | 2 | 11578874 | ||
| Pubmed | 3.65e-05 | 3 | 122 | 2 | 23721685 | ||
| Pubmed | 3.65e-05 | 3 | 122 | 2 | 26247833 | ||
| Pubmed | 3.65e-05 | 3 | 122 | 2 | 30054990 | ||
| Pubmed | Autocrine TGF-β1 Maintains the Stability of Foxp3+ Regulatory T Cells via IL-12Rβ2 Downregulation. | 3.65e-05 | 3 | 122 | 2 | 32471185 | |
| Pubmed | 3.65e-05 | 3 | 122 | 2 | 17339869 | ||
| Pubmed | 3.65e-05 | 3 | 122 | 2 | 28161714 | ||
| Interaction | SCGB2A2 interactions | SLC25A4 SLC25A6 BCHE H6PD ITGA4 TGFB1 SLIT2 COL14A1 DNAJC1 B4GALNT3 | 6.60e-07 | 223 | 116 | 10 | int:SCGB2A2 |
| Interaction | UGT1A9 interactions | 7.16e-07 | 13 | 116 | 4 | int:UGT1A9 | |
| Cytoband | 2q37 | 1.41e-06 | 31 | 122 | 4 | 2q37 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q37 | 3.35e-05 | 226 | 122 | 6 | chr2q37 | |
| GeneFamily | UDP glucuronosyltransferases | 3.10e-07 | 32 | 82 | 5 | 363 | |
| GeneFamily | Fibronectin type III domain containing | 8.12e-06 | 160 | 82 | 7 | 555 | |
| GeneFamily | N(alpha)-acetyltransferase subunits|GCN5 related N-acetyltransferases | 1.30e-03 | 12 | 82 | 2 | 660 | |
| ToppCell | metastatic_Brain-T/NK_cells-Cytotoxic_CD8+_T|T/NK_cells / Location, Cell class and cell subclass | 5.49e-06 | 161 | 122 | 6 | e6e294b4ba911c1327664f1a0f93207096c6de03 | |
| ToppCell | COVID-19-Heart-T_cell|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.75e-06 | 171 | 122 | 6 | b2e753e811a7639956994609f73efcdb62d04f82 | |
| ToppCell | facs-Lung-nan-3m-Lymphocytic-CD8-positive,_alpha-beta_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.56e-06 | 174 | 122 | 6 | 1c073177c1753e3b91ef8fd9e95230a1d13c82f3 | |
| ToppCell | facs-Lung-nan-3m-Lymphocytic-CD8+_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.56e-06 | 174 | 122 | 6 | 5491ad5c144baf2ef9b1c58eb720c872d14feb15 | |
| ToppCell | Control-Epithelial-Basal|World / Disease state, Lineage and Cell class | 1.11e-05 | 182 | 122 | 6 | 759390dde9b18757f7675d13d44c89d0e32f8d93 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-Glial_immature-Glia_1_(DHH+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.14e-05 | 183 | 122 | 6 | 547b1fb9f9940cfc8d6e351d96acc0da44def57e | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Neuronal-Glial_immature-Glia_1_(DHH+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.21e-05 | 185 | 122 | 6 | dd17025d8c423aa0a451ac7f1f301c93528e0229 | |
| ToppCell | Bronchus_Control_(B.)-Stromal-TX-Mesothelial-2|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 1.83e-05 | 199 | 122 | 6 | 60a653100aff31f7f96796ff2ec634798bfb4b0d | |
| ToppCell | 10x5'-Lung-Lymphocytic_T_CD4-T_CD4/CD8|Lung / Manually curated celltypes from each tissue | 7.03e-05 | 156 | 122 | 5 | 10d191e29b16cae8238e8df6c0ff38882253f34e | |
| ToppCell | facs-Heart-RV-24m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.46e-05 | 158 | 122 | 5 | 2ef43d14ee65d004dc62c12ff209bbe12e4db681 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-chondrocyte-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.46e-05 | 158 | 122 | 5 | e5636c0b608d68bd426a2b446ac508e4512e86a4 | |
| ToppCell | facs-Lung-3m-Hematologic-lymphocytic-CD8-positive,_alpha-beta_T_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.69e-05 | 159 | 122 | 5 | 4750ba9ca06ed97b18df3c74eeb51d3ac8763f63 | |
| ToppCell | wk_08-11-Mesenchymal-Fibroblast-Alveolar_fibro|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 9.42e-05 | 166 | 122 | 5 | 65dafed953b01a9830b54309af75c7a561e88336 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-myeloid_dendritic_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.02e-04 | 169 | 122 | 5 | b2d53159e344fad6fcdc485d5b8f6cf1bf094b1f | |
| ToppCell | Mild-CD4+_T_Exhausted|World / Disease group and Cell class | 1.11e-04 | 172 | 122 | 5 | efe68d9477aa873b1637ee689f298120303aa322 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-04 | 174 | 122 | 5 | f1fe1f4216748a9562dd03bd48c70b23c7ff4d1d | |
| ToppCell | facs-Skin-nan-24m-Epithelial-outer_bulge|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-04 | 175 | 122 | 5 | f1166b567bca80dac3abe90c3dc544c831006640 | |
| ToppCell | facs-Lung-nan-3m-Epithelial-club_cell_of_bronchiole|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.27e-04 | 177 | 122 | 5 | e5070934c674a46e070b0d52b9a374516bf6aea1 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.27e-04 | 177 | 122 | 5 | 64b8f665fdaf975558af2ad7d9b54d206de8350c | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Degenerative_Distal_Convoluted_Tubule_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.27e-04 | 177 | 122 | 5 | dc846d0feb94d4c289553cc3ac9dac81d10409cb | |
| ToppCell | facs-Lung-nan-3m-Epithelial-Club_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.27e-04 | 177 | 122 | 5 | b37d821f4f3204daf7c568ac17a0af0ba97273d6 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.31e-04 | 178 | 122 | 5 | fcbbcc44271515de1969b4732b6441c012693d5f | |
| ToppCell | droplet-Bladder-Unstain-18m-Epithelial-granulocyte-monocyte_progenitor|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.34e-04 | 179 | 122 | 5 | 804aa3899585fc7e662eff9f6d41f48655f16dd6 | |
| ToppCell | facs-Large_Intestine-Proximal-18m-Epithelial-enteroendocrine_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.38e-04 | 180 | 122 | 5 | 9db9899ca42455310e9b63df523fe6c4780abfb7 | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.38e-04 | 180 | 122 | 5 | 08ae0f5d95c45feba68ad99788f7af7ff4c979af | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.38e-04 | 180 | 122 | 5 | 9b1de1b4711adbf9a423f4d2d08f3f4c78f1f8f4 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-Reg_T-D|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.38e-04 | 180 | 122 | 5 | 5bf5878be3230d38c8e65fb954f326d567e1b520 | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.41e-04 | 181 | 122 | 5 | 9e7d0f1afb8d9bc5a209ddb5314df3a25a0274d9 | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Treg_cell_3|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.41e-04 | 181 | 122 | 5 | b193f3606554adc55c5906219d114288bb1f978a | |
| ToppCell | HSPCs-Erythroblasts|World / Lineage and Cell class | 1.41e-04 | 181 | 122 | 5 | ce26f1accc8f69b7bc4b929073e975c887566c6a | |
| ToppCell | COPD-Epithelial-Basal|COPD / Disease state, Lineage and Cell class | 1.49e-04 | 183 | 122 | 5 | 0f760e393edc91009bf6c7e02eeac039a1dfb4ed | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-4|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 1.53e-04 | 184 | 122 | 5 | 67164bb6bcae7322cb89b585c7aa10bce35b0ecd | |
| ToppCell | AT2_cells-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 1.56e-04 | 185 | 122 | 5 | 3b3268e3f99121124e33086cac88479808d31630 | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Macroglial-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.56e-04 | 185 | 122 | 5 | 554c5d812197fbf66bf279fcc953277e926ade15 | |
| ToppCell | (5)_Epithelial_cells-(5)_Glands_duct|(5)_Epithelial_cells / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 1.60e-04 | 186 | 122 | 5 | 219b1aeca17503244fabbb780bca58f22c7c0f27 | |
| ToppCell | (5)_Glands_duct|World / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 1.60e-04 | 186 | 122 | 5 | ad8d5010e5095508f4995e0c6c016a44e8ffb8dd | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.4.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.60e-04 | 186 | 122 | 5 | 07d94d5d1c2fe7bb909a07ca81058a0eabc65c60 | |
| ToppCell | droplet-Lung-3m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.69e-04 | 188 | 122 | 5 | b382d18fb09fb2869f3c151efa71540a7f5ed229 | |
| ToppCell | COVID-19-lung-Plasma_cells_PRDM1/BLIMP_int|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.69e-04 | 188 | 122 | 5 | 599195338070ac6b79bd114609d9e10cac4f1df4 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.73e-04 | 189 | 122 | 5 | a153b83314cf52808f685296cff8c95af3f4983d | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.73e-04 | 189 | 122 | 5 | e9d5e858e320c6e9913c1ea6a54967d21eda605f | |
| ToppCell | 10x_3'_v3-bone_marrow_(10x_3'_v3)-lymphocytic-B_lymphocytic|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.77e-04 | 190 | 122 | 5 | a21d0c574abf21e7cb865a21a48f29c92d055fbe | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell-D175|Adult / Lineage, Cell type, age group and donor | 1.77e-04 | 190 | 122 | 5 | 7dcca3469f3a3b70db0420cb94f7765f39492f06 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.77e-04 | 190 | 122 | 5 | 841cd55861b43578d704418b9bc0af2e8b88323a | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.77e-04 | 190 | 122 | 5 | d60395739458d7f47a3350ade751fe3819500320 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-mesothelial_cell|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.81e-04 | 191 | 122 | 5 | 5343a527de6b0f852f45020a91f5b4869e78f13a | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-mesothelial_cell-Mesothelium|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.81e-04 | 191 | 122 | 5 | a25a5f9a380031fdaf57677a079f97a90f0550c0 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.86e-04 | 192 | 122 | 5 | 6f4ef24dab544681304b7f8a9dc073e7edaa4cf5 | |
| ToppCell | NS-moderate-d_16-33-Lymphoid-Treg|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.86e-04 | 192 | 122 | 5 | 48d557071bad80edd3ec6e5ad8dcd97037da9553 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.86e-04 | 192 | 122 | 5 | f4fc2b0121f879bab2bee99dfb5ff2c3ca1c0e1b | |
| ToppCell | moderate-Lymphoid-Treg|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.86e-04 | 192 | 122 | 5 | e370ff5aaff7b7042ba9aaf93de43aa563b8b9f9 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.86e-04 | 192 | 122 | 5 | df1545670370fb1010c567cd059c2783eab315f7 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.86e-04 | 192 | 122 | 5 | dcd924d6eb67d33ee9f5d3e8ab6e1d4283d6b708 | |
| ToppCell | LPS_only-Stromal_mesenchymal|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.86e-04 | 192 | 122 | 5 | 162d8b5858d150ecbbd1c9bf2b19c6c9cd50a158 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.86e-04 | 192 | 122 | 5 | 3d0cb19f037f604253d7d728689aeaa94251e92b | |
| ToppCell | Healthy_Control-Lymphoid-T-CCR7+_T|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 1.86e-04 | 192 | 122 | 5 | 5b197f65a87c315e4f50c77a7fdec3b342a863ad | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.86e-04 | 192 | 122 | 5 | 4e47a02007f562f29ba5910df64d32a0167d0bd1 | |
| ToppCell | IPF-Epithelial-Basal|World / Disease state, Lineage and Cell class | 1.86e-04 | 192 | 122 | 5 | 9b91e0b162e6f3ce86dd15cc33c2e745d069581f | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.86e-04 | 192 | 122 | 5 | ee085e04d5dcfb657522484ed20b8c1ddeccfe0c | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-NK-NK-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.86e-04 | 192 | 122 | 5 | 6d7dd35869d86c3e991a61e17825053a3bfab44d | |
| ToppCell | (7)_Epithelial-C_(AT2)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.90e-04 | 193 | 122 | 5 | a3ca6ab20c8de260e410ddc14d3d202f28b9d6c2 | |
| ToppCell | Smart-seq2-thymus_(Smart-seq2)-lymphocytic-B_lymphocytic-plasma_cell|thymus_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.90e-04 | 193 | 122 | 5 | bd82961502db42a0c862d3a29a2babe8032384c8 | |
| ToppCell | Control-Lymphoid-T|Control / Disease state, Lineage and Cell class | 1.90e-04 | 193 | 122 | 5 | af928046ccd1ca874be1534aef6ca7f27d90bc46 | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.90e-04 | 193 | 122 | 5 | ea345d34440b25f65358a53dc72831998d1c3620 | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Cervical_Carcinoma-Keratinizing_Cervical_Squamous_Cell_Carcinoma-2|TCGA-Cervix / Sample_Type by Project: Shred V9 | 1.92e-04 | 104 | 122 | 4 | 57d2a707aacaa90f92895b87f4ecf87b7451d667 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.95e-04 | 194 | 122 | 5 | 6e13549f697f7478b34fe71f7dd9d63c5d3db22e | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.95e-04 | 194 | 122 | 5 | 46266d3d9af7000dc1381b1c8e55047193cbcf94 | |
| ToppCell | Adult-Immune-T_lymphocyte-D231|Adult / Lineage, Cell type, age group and donor | 1.95e-04 | 194 | 122 | 5 | 5c1dca33f382f37a7deb23e573578343c3b54986 | |
| ToppCell | Brain_organoid-organoid_Velasco_nature-3_mon-Neuronal-CFuPNs|3_mon / Sample Type, Dataset, Time_group, and Cell type. | 2.00e-04 | 195 | 122 | 5 | 574354ef4bcefeb9856b65d19bb92e2cffe5dc7a | |
| ToppCell | wk_20-22-Epithelial-Distal_epithelial-type_II_pneumocyte|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.00e-04 | 195 | 122 | 5 | 45d1acd316d0ced97dfb150c3a943128d8fa4e7e | |
| ToppCell | Severe-B_naive-2|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.05e-04 | 196 | 122 | 5 | 8ed9784684de0a31e4d20a79486e9b638d5a2605 | |
| ToppCell | 10x5'v1-week_17-19-Mesenchymal_osteo-stroma-osteoblast_precursor|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.05e-04 | 196 | 122 | 5 | 57df2a57b35be9851ac0b1e5731baa53052511f0 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.05e-04 | 196 | 122 | 5 | 22538376a95fe3afe8639a216a5497087aa94110 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.1.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.05e-04 | 196 | 122 | 5 | b1abecc0aafc09ca70a5fde624f2a998c4aa3341 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid|BALF-PFMC / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.05e-04 | 196 | 122 | 5 | 6361c37b0292ba9e5bf485a4809d2b0cd894c26e | |
| ToppCell | Children_(3_yrs)-Mesenchymal|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.05e-04 | 196 | 122 | 5 | bc94909f9b2dc08a59eef1914148b69720569c8f | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.09e-04 | 197 | 122 | 5 | 479841809554a9d0b1e4f23da6e657392b0f4971 | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_2-Differentiating_AT2|Control_saline / Treatment groups by lineage, cell group, cell type | 2.09e-04 | 197 | 122 | 5 | 44a59dfb889577b3160a5b13ada1276771a00241 | |
| ToppCell | Sepsis-ICU-SEP-Lymphocyte-T/NK-NK_CD56bright|ICU-SEP / Disease, condition lineage and cell class | 2.09e-04 | 197 | 122 | 5 | c187e3fc2160b0165eb039cf09a6e621016068b7 | |
| ToppCell | Mesenchymal_cells-Arteriolar_fibro.|Mesenchymal_cells / Lineage and Cell class | 2.09e-04 | 197 | 122 | 5 | cb321836980e7b4efbb9284c6af7ccd34079d2be | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Hematopoietic-Megakaryocytic-Megakaryocyte-Mega|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.14e-04 | 198 | 122 | 5 | 5cfd1c030c0940136a397b5a4b5d6ecbaecf72eb | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Hematopoietic-Megakaryocytic|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.14e-04 | 198 | 122 | 5 | ff6d9455ebfe965cc6f48197172c0ebd3bddde81 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Hematopoietic|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.14e-04 | 198 | 122 | 5 | 5375a2895cf995f0db4a61861093f01794707901 | |
| ToppCell | 5'-Adult-Appendix-Endothelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.14e-04 | 198 | 122 | 5 | 90e85fe7a0ab376a41666dfff6c0e95b7f1c9475 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Hematopoietic-Megakaryocytic-Megakaryocyte|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.14e-04 | 198 | 122 | 5 | 35edf6d5bedc2181fbdd56f43e458bc39f4eca16 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.19e-04 | 199 | 122 | 5 | 103f657132e830a0e5efeb745afb4b77c208a1fa | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 2.19e-04 | 199 | 122 | 5 | c2c42ecf20d1924edc2f899c01dfa5fcf3c210b9 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.19e-04 | 199 | 122 | 5 | 30d3e8c0681ec11f86dd38c5f48d21187a1b4f90 | |
| ToppCell | Tracheal-10x3prime_v2-Immune_Lymphocytic-T-T_CD4-CD4|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.19e-04 | 199 | 122 | 5 | 01ae5ce8e0a1d3bd1cc975b16f53c13bbc13189d | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_submucosal-gland-SMG_Duct|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.22e-04 | 108 | 122 | 4 | 9c7f3e25facfb54ef0be45044999bc36438bbea0 | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_submucosal-gland|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.22e-04 | 108 | 122 | 4 | 75d635fc5bb004418db2e1328c24d96b718f10b1 | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic|Control_saline / Treatment groups by lineage, cell group, cell type | 2.25e-04 | 200 | 122 | 5 | 64ae5cf6cb4fc94cf1052abd82648f6b8e6445fe | |
| ToppCell | normal_Lung-Fibroblasts|normal_Lung / Location, Cell class and cell subclass | 2.25e-04 | 200 | 122 | 5 | 803cf7f1382d07220249029cd220233232027689 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Fibroblastic-Fibro_adventitial|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.25e-04 | 200 | 122 | 5 | fc3c4778841c4b8bac0afb458352614b2c460617 | |
| ToppCell | distal-mesenchymal-Adventitial_Fibroblast-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.25e-04 | 200 | 122 | 5 | 56e838787385dd282caadeac24fbb0a706bf7f2b | |
| ToppCell | Biopsy_IPF-Immune-T_cells|Biopsy_IPF / Sample group, Lineage and Cell type | 2.25e-04 | 200 | 122 | 5 | 368c7334d211054f1e914a1be4027aa75e2df66c | |
| ToppCell | distal-1-mesenchymal-Adventitial_Fibroblast|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.25e-04 | 200 | 122 | 5 | 738060ed65fa5473fdb39e686f7cdecc059ed92c | |
| ToppCell | wk_15-18-Mesenchymal|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.25e-04 | 200 | 122 | 5 | 4d484260ecbbbd9f820b445bdcc2666f6c464b73 | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts|Control_saline / Treatment groups by lineage, cell group, cell type | 2.25e-04 | 200 | 122 | 5 | a1fc74c1b27e104895910bc7cdce7ba33d30df7e | |
| ToppCell | Tracheal-NucSeq-Immune_Lymphocytic-B-B_cell-B_naive|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.25e-04 | 200 | 122 | 5 | 4f7be296be0cd54cfc62cc93263fde26210c61f4 | |
| Drug | naringenin chalcone | 3.78e-09 | 5 | 121 | 4 | ctd:C027329 | |
| Drug | anthrarobin | 3.78e-09 | 5 | 121 | 4 | ctd:C032186 | |
| Drug | 1,2,5,8-tetrahydroxy anthraquinone | 1.13e-08 | 6 | 121 | 4 | ctd:C543211 | |
| Drug | alloin | 1.13e-08 | 6 | 121 | 4 | ctd:C006457 | |
| Drug | 2',5'-dihydroxychalcone | 1.13e-08 | 6 | 121 | 4 | ctd:C107497 | |
| Drug | indole-2-carboxylic acid | 1.61e-08 | 32 | 121 | 6 | CID000072899 | |
| Drug | 2',4'-dihydroxychalcone | 2.62e-08 | 7 | 121 | 4 | ctd:C059354 | |
| Drug | AC1NOWCJ | 2.85e-08 | 35 | 121 | 6 | CID005120112 | |
| Drug | C1 11-32 | 3.16e-08 | 18 | 121 | 5 | CID000443077 | |
| Drug | C11131 | 3.16e-08 | 18 | 121 | 5 | CID000443076 | |
| Drug | almokalant | 4.27e-08 | 19 | 121 | 5 | CID003033962 | |
| Drug | 3-OHBaP | 4.35e-08 | 63 | 121 | 7 | CID000025890 | |
| Drug | 1,4-dihydroxyanthraquinone | 5.23e-08 | 8 | 121 | 4 | ctd:C034890 | |
| Drug | puerarin | 5.32e-08 | 98 | 121 | 8 | ctd:C033607 | |
| Drug | 3-hydroxyandrostan-17-one | 7.28e-08 | 102 | 121 | 8 | CID000000225 | |
| Drug | estriol-16-glucuronide | 7.42e-08 | 21 | 121 | 5 | CID000122281 | |
| Drug | Meldola | 7.45e-08 | 68 | 121 | 7 | CID000081507 | |
| Drug | AC1MRQNQ | 9.37e-08 | 9 | 121 | 4 | CID003522271 | |
| Drug | DHPASiU | 9.37e-08 | 9 | 121 | 4 | CID000197602 | |
| Drug | 3-iodophenol | 9.37e-08 | 9 | 121 | 4 | CID000012272 | |
| Drug | AC1L4J7U | 9.37e-08 | 9 | 121 | 4 | CID000186631 | |
| Drug | Chebi:32663 | 9.37e-08 | 9 | 121 | 4 | CID005460873 | |
| Drug | estradiol-3-glucuronide | 1.22e-07 | 23 | 121 | 5 | CID000066651 | |
| Drug | Clodronate | 1.46e-07 | 3 | 121 | 3 | DB00720 | |
| Drug | AS-3201 | 1.53e-07 | 24 | 121 | 5 | CID000153948 | |
| Drug | Glucuronides | 1.55e-07 | 10 | 121 | 4 | ctd:D020719 | |
| Drug | 2,6-dihydroxyanthraquinone | 1.55e-07 | 10 | 121 | 4 | ctd:C034889 | |
| Drug | 5-MOP | 1.90e-07 | 25 | 121 | 5 | CID000002355 | |
| Drug | 5,6-benzoquinoline | 1.90e-07 | 25 | 121 | 5 | CID000006796 | |
| Drug | Thymol | 2.35e-07 | 26 | 121 | 5 | ctd:D013943 | |
| Drug | 4-nitrophenyl)imidazole | 2.43e-07 | 11 | 121 | 4 | CID000123155 | |
| Drug | AC1O5XMV | 2.43e-07 | 11 | 121 | 4 | CID006442661 | |
| Drug | AC1NQGK1 | 3.32e-07 | 52 | 121 | 6 | CID005195977 | |
| Drug | N-OH-DABZ | 3.64e-07 | 12 | 121 | 4 | CID000051366 | |
| Drug | 1-O-beta-D-glucopyranosyl-D-mannitol | 3.64e-07 | 12 | 121 | 4 | CID000088735 | |
| Drug | 4-hydroxyestrone | 3.64e-07 | 12 | 121 | 4 | ctd:C026418 | |
| Drug | 2,4,6-TCB | 3.64e-07 | 12 | 121 | 4 | CID000037247 | |
| Drug | nonanoyl-N-methylglucamide | 3.64e-07 | 12 | 121 | 4 | CID000160090 | |
| Drug | 7,7,7-triphenylheptanoic acid | 3.64e-07 | 12 | 121 | 4 | CID000276709 | |
| Drug | 7-hydroxycoumarin glucuronide | 4.18e-07 | 29 | 121 | 5 | CID000125641 | |
| Drug | trans-3'-hydroxycotinine | 4.18e-07 | 29 | 121 | 5 | CID000000414 | |
| Drug | paricalcitol | 5.00e-07 | 30 | 121 | 5 | CID005281104 | |
| Drug | AC1L9E0Q | 5.00e-07 | 30 | 121 | 5 | CID000443095 | |
| Drug | 2-hydroxyestrone | 5.23e-07 | 13 | 121 | 4 | ctd:C024980 | |
| Drug | tritanol | 5.23e-07 | 13 | 121 | 4 | CID000006457 | |
| Drug | 5-azido-UDP-glucuronic acid | 5.23e-07 | 13 | 121 | 4 | CID003081279 | |
| Drug | cotinine-N-glucuronide | 5.23e-07 | 13 | 121 | 4 | CID000000411 | |
| Drug | alizarin | 5.23e-07 | 13 | 121 | 4 | ctd:C010078 | |
| Drug | hydratropic acid | 5.83e-07 | 4 | 121 | 3 | ctd:C013025 | |
| Drug | dehydroabietylamine | 5.83e-07 | 4 | 121 | 3 | ctd:C000600819 | |
| Drug | 2-vanillin | 5.83e-07 | 4 | 121 | 3 | ctd:C060843 | |
| Drug | diphenylacetic acid | 5.83e-07 | 4 | 121 | 3 | ctd:C037760 | |
| Drug | phenolphthalein | 6.42e-07 | 58 | 121 | 6 | CID000004764 | |
| Drug | 4-hydroxybiphenyl | 7.12e-07 | 59 | 121 | 6 | CID000007103 | |
| Drug | SN-38G | 7.12e-07 | 59 | 121 | 6 | CID000443154 | |
| Drug | propranolol glucuronide | 7.29e-07 | 14 | 121 | 4 | CID000119515 | |
| Drug | PCB-61 | 7.29e-07 | 14 | 121 | 4 | CID000036401 | |
| Drug | norbuprenorphine | 8.22e-07 | 33 | 121 | 5 | CID000114976 | |
| Drug | AC1Q6OQG | 8.22e-07 | 33 | 121 | 5 | CID000009686 | |
| Drug | aniline | 9.33e-07 | 142 | 121 | 8 | CID000006115 | |
| Drug | 2,2',3,5,5'-pentachlorobiphenyl | 9.90e-07 | 15 | 121 | 4 | CID000040469 | |
| Drug | afloqualone | 9.90e-07 | 15 | 121 | 4 | CID000002040 | |
| Drug | naphthyl sulphate | 9.90e-07 | 15 | 121 | 4 | CID000114775 | |
| Drug | coumarin-3-carboxylic acid | 9.90e-07 | 15 | 121 | 4 | CID000010752 | |
| Drug | bergamottin | 9.90e-07 | 15 | 121 | 4 | ctd:C068337 | |
| Drug | sulforaphane nitrile | 9.90e-07 | 15 | 121 | 4 | CID000543743 | |
| Drug | 3-[(3S,5R,10S,13R,14S,17R)-3-[(2S,4R,5R,6S)-4,5-dihydroxy-6-methyloxan-2-yl]oxy-14-hydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2H-furan-5-one | 1.11e-06 | 35 | 121 | 5 | CID010436171 | |
| Drug | estrone-3-glucuronide | 1.11e-06 | 35 | 121 | 5 | CID000115255 | |
| Drug | Fenspiride hydrochloride [5053-08-7]; Up 200; 13.4uM; PC3; HT_HG-U133A | 1.21e-06 | 199 | 121 | 9 | 7298_UP | |
| Drug | quercetin-3,4'-diglucoside | 1.31e-06 | 16 | 121 | 4 | CID005320835 | |
| Drug | 1'-hydroxyestragole | 1.31e-06 | 16 | 121 | 4 | CID000040003 | |
| Drug | bilirubin-phosphate | 1.31e-06 | 16 | 121 | 4 | CID005497144 | |
| Drug | isovaleric acid | 1.45e-06 | 5 | 121 | 3 | ctd:C008216 | |
| Drug | biphenylylacetic acid | 1.45e-06 | 5 | 121 | 3 | ctd:C012776 | |
| Drug | galangin | 1.66e-06 | 68 | 121 | 6 | ctd:C037032 | |
| Drug | formononetin | 1.70e-06 | 38 | 121 | 5 | ctd:C007768 | |
| Drug | 4-methylumbelliferyl glucuronide | 1.70e-06 | 38 | 121 | 5 | CID000091553 | |
| Drug | x Me | 1.70e-06 | 38 | 121 | 5 | CID009600424 | |
| Drug | 3 beta,5 alpha,25R)- 3-hydroxyspirostan-12-one | 1.71e-06 | 17 | 121 | 4 | CID000003573 | |
| Drug | 6-hydroxychrysene | 1.71e-06 | 17 | 121 | 4 | CID000037766 | |
| Drug | acetaminophen | TNFRSF25 ANPEP UGT1A10 UGT1A8 UGT1A7 UGT1A9 H6PD EPX AASS UGT2A3 | 1.86e-06 | 270 | 121 | 10 | CID000001983 |
| Drug | Fenoprofen | 2.19e-06 | 18 | 121 | 4 | ctd:D005279 | |
| Drug | SureCN12722713 | 2.19e-06 | 18 | 121 | 4 | CID005488034 | |
| Drug | ethyl-beta-D-6-glucosiduronic acid | 2.19e-06 | 18 | 121 | 4 | CID000152226 | |
| Drug | Br 2 | 2.19e-06 | 18 | 121 | 4 | CID003060900 | |
| Drug | 2,3,7-trichlorodibenzo-p-dioxin | 2.19e-06 | 18 | 121 | 4 | CID000036614 | |
| Drug | ApApG | 2.19e-06 | 18 | 121 | 4 | CID003081975 | |
| Drug | harmol | 2.21e-06 | 40 | 121 | 5 | CID000068094 | |
| Drug | testosterone glucuronide | 2.51e-06 | 41 | 121 | 5 | CID000108192 | |
| Drug | 2,2,2-trichloroethanol | 2.53e-06 | 73 | 121 | 6 | CID000008259 | |
| Drug | Masoprocol | 2.74e-06 | 74 | 121 | 6 | ctd:D009637 | |
| Drug | 9-OH-risperidone | 2.77e-06 | 19 | 121 | 4 | CID000475100 | |
| Drug | 5alpha-spirostan-3beta-ol | 2.77e-06 | 19 | 121 | 4 | CID000091433 | |
| Drug | 3-phenylpropionic acid | 2.89e-06 | 6 | 121 | 3 | ctd:C035253 | |
| Drug | Indoprofen | 2.89e-06 | 6 | 121 | 3 | ctd:D007216 | |
| Drug | 7-hydroxycoumarin | 2.97e-06 | 75 | 121 | 6 | CID005281426 | |
| Drug | androsterone glucuronide | 3.20e-06 | 43 | 121 | 5 | CID000114833 | |
| Drug | tectochrysin | 3.44e-06 | 20 | 121 | 4 | CID005281954 | |
| Drug | AC1L1OBF | 3.44e-06 | 20 | 121 | 4 | CID000032736 | |
| Drug | 4'-hydroxydiclofenac | 3.44e-06 | 20 | 121 | 4 | CID000116545 | |
| Disease | N-acetyl-4-chlorophenylalanine measurement | 1.02e-09 | 5 | 113 | 4 | EFO_0801060 | |
| Disease | 5-hydroxyindole sulfate measurement | 1.02e-09 | 5 | 113 | 4 | EFO_0800085 | |
| Disease | nuclear receptor subfamily 1 group D member 2 measurement | 1.02e-09 | 5 | 113 | 4 | EFO_0801853 | |
| Disease | X-21339 measurement | 7.07e-09 | 7 | 113 | 4 | EFO_0800808 | |
| Disease | X-11793--oxidized bilirubin measurement | 1.41e-08 | 8 | 113 | 4 | EFO_0021260 | |
| Disease | Succinimide measurement | 1.41e-08 | 8 | 113 | 4 | EFO_0022118 | |
| Disease | X-11530 measurement | 1.41e-08 | 8 | 113 | 4 | EFO_0021249 | |
| Disease | sulfate of piperine metabolite C16H19NO3 (2) measurement | 1.41e-08 | 8 | 113 | 4 | EFO_0801034 | |
| Disease | cholelithiasis, bilirubin measurement | 1.41e-08 | 8 | 113 | 4 | EFO_0004570, EFO_0004799 | |
| Disease | X-11522 measurement | 1.41e-08 | 8 | 113 | 4 | EFO_0800696 | |
| Disease | X-10458 measurement | 1.41e-08 | 8 | 113 | 4 | EFO_0800692 | |
| Disease | X-24849 measurement | 1.41e-08 | 8 | 113 | 4 | EFO_0800909 | |
| Disease | serum N-desmethylclozapine measurement | 1.41e-08 | 8 | 113 | 4 | EFO_0600043 | |
| Disease | plasma clozapine measurement | 1.41e-08 | 8 | 113 | 4 | EFO_0600038 | |
| Disease | membrane-associated progesterone receptor component 1 measurement | 1.41e-08 | 8 | 113 | 4 | EFO_0802740 | |
| Disease | X-16946 measurement | 1.41e-08 | 8 | 113 | 4 | EFO_0800766 | |
| Disease | X-11442 measurement | 2.53e-08 | 9 | 113 | 4 | EFO_0021236 | |
| Disease | X-11441 measurement | 2.53e-08 | 9 | 113 | 4 | EFO_0021235 | |
| Disease | circulating cell free DNA measurement | 2.53e-08 | 9 | 113 | 4 | EFO_0004739 | |
| Disease | sulfate of piperine metabolite C18H21NO3 (3) measurement | 2.53e-08 | 9 | 113 | 4 | EFO_0801037 | |
| Disease | sulfate of piperine metabolite C18H21NO3 (1) measurement | 2.53e-08 | 9 | 113 | 4 | EFO_0801036 | |
| Disease | X-11880 measurement | 2.53e-08 | 9 | 113 | 4 | EFO_0800698 | |
| Disease | protein-tyrosine kinase 6 measurement | 2.53e-08 | 9 | 113 | 4 | EFO_0020691 | |
| Disease | testis-specific chromodomain protein Y 1 measurement | 2.53e-08 | 9 | 113 | 4 | EFO_0802127 | |
| Disease | bilirubin measurement, response to xenobiotic stimulus | 2.53e-08 | 9 | 113 | 4 | EFO_0004570, GO_0009410 | |
| Disease | bilirubin measurement, response to tenofovir | 4.21e-08 | 10 | 113 | 4 | EFO_0004570, EFO_0009279 | |
| Disease | indoleacetate measurement | 4.21e-08 | 10 | 113 | 4 | EFO_0021015 | |
| Disease | X-21448 measurement | 4.21e-08 | 10 | 113 | 4 | EFO_0800816 | |
| Disease | UDP-glucuronosyltransferase 1-6 measurement | 4.21e-08 | 10 | 113 | 4 | EFO_0802185 | |
| Disease | X-23974 measurement | 4.21e-08 | 10 | 113 | 4 | EFO_0800867 | |
| Disease | indole-3-carboxylate measurement | 5.47e-08 | 3 | 113 | 3 | EFO_0800043 | |
| Disease | blood 4-oxo-retinoic acid measurement | 5.47e-08 | 3 | 113 | 3 | EFO_0022216 | |
| Disease | pregnenetriol sulfate measurement | 6.59e-08 | 11 | 113 | 4 | EFO_0800586 | |
| Disease | plasma N-desmethylclozapine measurement | 6.59e-08 | 11 | 113 | 4 | EFO_0600039 | |
| Disease | histidine betaine (hercynine) measurement | 6.59e-08 | 11 | 113 | 4 | EFO_0800972 | |
| Disease | X-21796 measurement | 6.59e-08 | 11 | 113 | 4 | EFO_0800825 | |
| Disease | insomnia, bilirubin measurement | 6.59e-08 | 11 | 113 | 4 | EFO_0004570, EFO_0004698 | |
| Disease | aldosterone measurement | 6.59e-08 | 11 | 113 | 4 | EFO_0010219 | |
| Disease | p-cresol glucuronide measurement | 9.86e-08 | 12 | 113 | 4 | EFO_0800079 | |
| Disease | biliverdin measurement | 9.86e-08 | 12 | 113 | 4 | EFO_0021033 | |
| Disease | pregnenetriol disulfate measurement | 1.42e-07 | 13 | 113 | 4 | EFO_0800587 | |
| Disease | retinol dehydrogenase 16 measurement | 1.42e-07 | 13 | 113 | 4 | EFO_0802007 | |
| Disease | autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 2 (implicated_via_orthology) | 2.18e-07 | 4 | 113 | 3 | DOID:0111517 (implicated_via_orthology) | |
| Disease | vitamin D deficiency | 2.98e-07 | 37 | 113 | 5 | EFO_0003762 | |
| Disease | low density lipoprotein cholesterol measurement, body fat percentage | 4.67e-07 | 17 | 113 | 4 | EFO_0004611, EFO_0007800 | |
| Disease | X-21441 measurement | 4.67e-07 | 17 | 113 | 4 | EFO_0800814 | |
| Disease | angiopoietin-related protein 1 measurement | 5.99e-07 | 18 | 113 | 4 | EFO_0801382 | |
| Disease | 3-carboxy-4-methyl-5-pentyl-2-furanpropionate (3-CMPFP) measurement | 1.08e-06 | 6 | 113 | 3 | EFO_0800566 | |
| Disease | tissue factor measurement | 1.16e-06 | 21 | 113 | 4 | EFO_0010623 | |
| Disease | vitamin D measurement, COVID-19 | 1.26e-06 | 49 | 113 | 5 | EFO_0004631, MONDO_0100096 | |
| Disease | type 2 diabetes mellitus (biomarker_via_orthology) | 1.64e-06 | 147 | 113 | 7 | DOID:9352 (biomarker_via_orthology) | |
| Disease | neuroblastoma, cutaneous melanoma | 3.89e-06 | 28 | 113 | 4 | EFO_0000389, EFO_0000621 | |
| Disease | xanthurenate measurement | 4.50e-06 | 29 | 113 | 4 | EFO_0010551 | |
| Disease | response to dolutegravir | 5.17e-06 | 30 | 113 | 4 | EFO_0600017 | |
| Disease | X-24588 measurement | 1.52e-05 | 13 | 113 | 3 | EFO_0800898 | |
| Disease | Cataract and cardiomyopathy | 4.35e-05 | 3 | 113 | 2 | C1859317 | |
| Disease | gallstones | 6.14e-05 | 108 | 113 | 5 | EFO_0004210 | |
| Disease | urate measurement, spine bone mineral density | 7.38e-05 | 58 | 113 | 4 | EFO_0004531, EFO_0007701 | |
| Disease | protein SERAC1 measurement | 8.68e-05 | 4 | 113 | 2 | EFO_0801963 | |
| Disease | growth factor receptor-bound protein 14 measurement | 8.68e-05 | 4 | 113 | 2 | EFO_0801658 | |
| Disease | dual specificity protein kinase CLK2 measurement | 1.44e-04 | 5 | 113 | 2 | EFO_0801548 | |
| Disease | dual specificity tyrosine-phosphorylation-regulated kinase 3 measurement | 1.44e-04 | 5 | 113 | 2 | EFO_0020337 | |
| Disease | tuftelin-interacting protein 11 measurement | 1.44e-04 | 5 | 113 | 2 | EFO_0803199 | |
| Disease | cellular tumor antigen p53 measurement | 1.44e-04 | 5 | 113 | 2 | EFO_0022006 | |
| Disease | a disintegrin and metalloproteinase with thrombospondin motifs 3 measurement | 1.44e-04 | 5 | 113 | 2 | EFO_0802245 | |
| Disease | proteasome subunit alpha type-1 measurement | 1.44e-04 | 5 | 113 | 2 | EFO_0020663 | |
| Disease | nuclear pore complex-interacting protein family member B3 measurement | 1.44e-04 | 5 | 113 | 2 | EFO_0801850 | |
| Disease | transcription factor RelB measurement | 1.44e-04 | 5 | 113 | 2 | EFO_0802140 | |
| Disease | transcription regulator protein BACH1 measurement | 1.44e-04 | 5 | 113 | 2 | EFO_0802141 | |
| Disease | m-phase inducer phosphatase 2 measurement | 1.44e-04 | 5 | 113 | 2 | EFO_0801780 | |
| Disease | heat shock 70 kDa protein 6 measurement | 1.44e-04 | 5 | 113 | 2 | EFO_0801666 | |
| Disease | heat shock 70 kDa protein 1-like measurement | 1.44e-04 | 5 | 113 | 2 | EFO_0801665 | |
| Disease | probable E3 ubiquitin-protein ligase HERC4 measurement | 1.44e-04 | 5 | 113 | 2 | EFO_0802903 | |
| Disease | hypertrophic cardiomyopathy (implicated_via_orthology) | 1.86e-04 | 29 | 113 | 3 | DOID:11984 (implicated_via_orthology) | |
| Disease | regulator of G-protein signaling 19 measurement | 2.16e-04 | 6 | 113 | 2 | EFO_0801996 | |
| Disease | ras-related protein Rab-35 measurement | 2.16e-04 | 6 | 113 | 2 | EFO_0801990 | |
| Disease | complement component 1 q subcomponent-binding protein, mitochondrial measurement | 2.16e-04 | 6 | 113 | 2 | EFO_0020280 | |
| Disease | peptidyl-prolyl cis-trans isomerase-like 2 measurement | 2.16e-04 | 6 | 113 | 2 | EFO_0801877 | |
| Disease | biglycan measurement | 2.16e-04 | 6 | 113 | 2 | EFO_0020182 | |
| Disease | transcription factor AP-1 measurement | 2.16e-04 | 6 | 113 | 2 | EFO_0021909 | |
| Disease | killer cell immunoglobulin-like receptor 2DL2 measurement | 2.16e-04 | 6 | 113 | 2 | EFO_0801744 | |
| Disease | secreted frizzled-related protein 2 measurement | 2.16e-04 | 6 | 113 | 2 | EFO_0802039 | |
| Disease | dermokine measurement | 2.16e-04 | 6 | 113 | 2 | EFO_0802462 | |
| Disease | inactive peptidyl-prolyl cis-trans isomerase FKBP6 measurement | 2.16e-04 | 6 | 113 | 2 | EFO_0801694 | |
| Disease | growth/differentiation factor 5 measurement | 2.16e-04 | 6 | 113 | 2 | EFO_0020429 | |
| Disease | thyroxine measurement | 2.97e-04 | 83 | 113 | 4 | EFO_0005130 | |
| Disease | bipolar disorder (implicated_via_orthology) | 3.01e-04 | 7 | 113 | 2 | DOID:3312 (implicated_via_orthology) | |
| Disease | myotubularin-related protein 1 measurement | 3.01e-04 | 7 | 113 | 2 | EFO_0802773 | |
| Disease | angiopoietin-related protein 4 measurement | 3.01e-04 | 7 | 113 | 2 | EFO_0020149 | |
| Disease | MAP kinase-activated protein kinase 5 measurement | 3.01e-04 | 7 | 113 | 2 | EFO_0020553 | |
| Disease | rho GTPase-activating protein 30 measurement | 3.01e-04 | 7 | 113 | 2 | EFO_0802012 | |
| Disease | RNA polymerase II elongation factor ELL measurement | 3.01e-04 | 7 | 113 | 2 | EFO_0802028 | |
| Disease | heterogeneous nuclear ribonucleoproteins C1/C2 measurement | 3.01e-04 | 7 | 113 | 2 | EFO_0801675 | |
| Disease | hormone measurement | 3.11e-04 | 84 | 113 | 4 | EFO_0004730 | |
| Disease | mitochondrial metabolism disease (implicated_via_orthology) | 3.27e-04 | 35 | 113 | 3 | DOID:700 (implicated_via_orthology) | |
| Disease | cholelithiasis | 3.71e-04 | 88 | 113 | 4 | EFO_0004799 | |
| Disease | CREB-binding protein measurement | 4.01e-04 | 8 | 113 | 2 | EFO_0801502 | |
| Disease | protein sel-1 homolog 2 measurement | 4.01e-04 | 8 | 113 | 2 | EFO_0801962 | |
| Disease | poly(A) RNA polymerase, mitochondrial measurement | 4.01e-04 | 8 | 113 | 2 | EFO_0801893 | |
| Disease | circulating alpha-Klotho measurement | 4.01e-04 | 8 | 113 | 2 | EFO_0020102 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RAENYAQIQNPSWLG | 296 | Q9H161 | |
| LGQFTLLFNPWNRED | 131 | P16452 | |
| WRGNLANVIRYFPTQ | 71 | P12236 | |
| RRLASYWAQPQDALS | 281 | Q53H12 | |
| NAPWAVTSLYEARNR | 256 | P06276 | |
| GNPLNRRYGSWRELA | 51 | Q6L9W6 | |
| NITQLILRNNPWYCG | 296 | Q9NZU0 | |
| YWEQNTPRLLTRQDA | 311 | Q9UDR5 | |
| WRGNLANVIRYFPTQ | 71 | P05141 | |
| ARLNSWNLGIENPRY | 206 | Q8N8E3 | |
| DQSKAWNRYRLPNTL | 66 | P15144 | |
| QLGVLRNGWSSQYPL | 11 | Q9NZJ0 | |
| RDWRRNYLLNPVNTF | 521 | A1A5B4 | |
| NPIALGSRWLAYAEN | 231 | Q9H6U6 | |
| ELALQQYPRGSSDRW | 506 | Q96KC8 | |
| QTPRLWLFGYDEQRQ | 211 | Q9NT62 | |
| RTANDGDYWRLLNPG | 671 | Q8N436 | |
| LAPRDGLWNGAQLYA | 796 | P52333 | |
| PGLNREQLYWELSQL | 12936 | Q8WXI7 | |
| SPGLDREQLYWQLSQ | 13091 | Q8WXI7 | |
| LAAAWYSGVNRPRNI | 286 | Q8WVX9 | |
| ARFLSSLWERLPQNN | 186 | Q9NPI8 | |
| RQVPNSNPARYEFLW | 261 | O15480 | |
| PRLFNLRSIYLQWNR | 226 | Q86VH4 | |
| WFLGNLRSNYTPRSN | 201 | O15151 | |
| APNRQPLANERAYWT | 111 | Q86VF7 | |
| IPNRNWTITDANRNY | 141 | Q96EF0 | |
| FWGFLTPRQRNLQRA | 531 | Q9UKN7 | |
| VQNYLYNVLERPRGW | 111 | Q9NR82 | |
| DTQVPLNWLRSRPYN | 466 | Q99665 | |
| LNWLRSRPYNVSALI | 471 | Q99665 | |
| DWYIRNSGLAAGPQR | 561 | Q96HB5 | |
| LPNGNLSYYIVRWQR | 636 | P08069 | |
| ELRRLNPRWNGDKLY | 401 | P11678 | |
| LQLRPTQRASWIGYA | 141 | Q6N069 | |
| GPTYQRRGSLQLWQF | 326 | P50549 | |
| LRGQNLTPYWALRLQ | 411 | A2RU67 | |
| LTPYWALRLQGLRSQ | 416 | A2RU67 | |
| YWNSSNPRLLRGDAV | 31 | P52798 | |
| FDGQPLGNFRRQLWL | 161 | Q9ULS6 | |
| LGNFRRQLWLALDNP | 166 | Q9ULS6 | |
| RQLWLALDNPGYSVL | 171 | Q9ULS6 | |
| NIYDILPWRQEDLGR | 91 | Q8IWV1 | |
| NRSWYLTENIQRFLP | 601 | P00451 | |
| PYQRRGSLQLWQFLV | 361 | P41161 | |
| AQYDNLWRLSLRPAE | 331 | Q9NQG6 | |
| VYNPARGEWRRISNI | 536 | Q8WVZ9 | |
| QFLLIGISNYPQWRD | 11 | Q8NG92 | |
| ENPALLRWAYARTIN | 61 | O95168 | |
| GLPTNCLALWAAYRQ | 31 | P46093 | |
| LQLRPAQRASWIGYA | 141 | Q9BXJ9 | |
| PRSNDGNSYRLQSWL | 121 | O95299 | |
| LNPIIYSLWNRDVQG | 286 | Q8NGR3 | |
| QARQLTLQWEPLGYN | 396 | Q92729 | |
| PNSSGSWLRYIQNRL | 236 | Q3SYC2 | |
| YLQAVQGRPLSCRWL | 176 | Q9H237 | |
| LRSWYARLPAVVQNA | 946 | Q8N0W3 | |
| FNRTLWAQLRAELGP | 286 | Q9H3Q3 | |
| NRTEPSILNNYLIWN | 496 | P0DPD8 | |
| YEIRQWNTDGLPRDL | 3046 | Q9C0G6 | |
| TLWYQAQLNRRVPEA | 776 | Q9H799 | |
| GPQNLRVSEEWYNRL | 831 | Q05707 | |
| LNRNRYGVEPLWRAS | 151 | A6NCJ1 | |
| WLANASVINPGAIYR | 76 | P13612 | |
| LPQRLQDAYGGWANR | 196 | Q9UEF7 | |
| NYNRAFQVWAVPLLL | 556 | Q8N4M1 | |
| WNPANDLQAIDRAYR | 616 | Q5T890 | |
| PFRDQNRKALDGLWN | 216 | O95479 | |
| DNYFPISNIRLWALQ | 66 | O75712 | |
| RLRWVPLPDSQYNGN | 1191 | Q7Z5N4 | |
| PYILAEAQLRTQRAW | 481 | Q2VPK5 | |
| RQAPVLLQTYRESWN | 241 | Q9H7T9 | |
| GAQLEARDRLKNWYP | 16 | Q9BVI0 | |
| LVAASPRTWRNNYRL | 26 | O60882 | |
| RQNLPWLFYGDQLGL | 291 | Q5HYA8 | |
| IRAQPQDLIQWGADY | 26 | Q9BZX4 | |
| AQGYPRNRLLSGDRW | 1061 | Q2M3C7 | |
| LPLADSRQRNYAWET | 111 | Q8NB59 | |
| QWRLQQGLAANPSGY | 26 | Q86TS9 | |
| LRNTRNPIWNETLVY | 451 | Q9Y2J0 | |
| AYRPDWNRLSGLTRA | 26 | Q8WWX9 | |
| FLRQQWNDPRLAYNE | 91 | P23415 | |
| QLRTADWRLYLFQAP | 861 | Q8NDX1 | |
| YGRWRFQIPAQRLFN | 201 | Q92561 | |
| AWLCRSQRRQGQPIY | 441 | O15079 | |
| WRNPLNLFRGAEYNR | 136 | Q9NRC1 | |
| FRGYALGQVPWLLNQ | 226 | Q7Z745 | |
| WSPAGLQSYQQALLR | 21 | Q9UJW9 | |
| YGRSPAQILLRWQVQ | 241 | P14550 | |
| WRGNLANVIRYFPTQ | 71 | P12235 | |
| GSPRVYWLGLNDRAQ | 306 | Q6ZS10 | |
| PWQDLARQNRFFTAL | 96 | A6NNL5 | |
| NFYPRGLQLTWLENG | 276 | O00241 | |
| WDRLCPAQRGLYRNV | 36 | P15622 | |
| LWRYTGTRPSNLANN | 331 | Q9HAW8 | |
| WALLDPGQRNIYRDV | 71 | Q9ULM2 | |
| NLADWLGSLDPRFRQ | 486 | Q6SZW1 | |
| VRNLLAPYEQRPWAQ | 951 | Q5XPI4 | |
| NNSWRYLSNRLLAPS | 176 | P01137 | |
| WSYGRQQGLSLLQVP | 201 | Q8TBR7 | |
| NSQENRNYLRLWTPE | 996 | Q6ZT07 | |
| WVLNLTGNRIYNPNS | 2631 | Q9H5I5 | |
| RARLYWLQVDNQLPG | 3201 | Q709C8 | |
| SDWLRQRPRVGLYTQ | 221 | O94813 | |
| LWRYTGTRPSNLANN | 331 | O60656 | |
| WSGPYILRNQDDREL | 71 | P40126 | |
| RWRQQQPAGLGAVYA | 381 | Q93038 | |
| PYDVNQLLGWDLNLS | 11 | Q9BZ97 | |
| LLWGYQLSQPDAASR | 246 | Q8TBC5 | |
| GANTRLYDWIPQNDL | 346 | Q6UWM9 | |
| EWGQLDSPQRALYRD | 56 | Q16587 | |
| EEWGQLSPAQRALYR | 26 | Q8N9F8 | |
| PDQLLAWQGLANLYE | 71 | Q6PGP7 | |
| RTLALYALPQSGWQA | 126 | A0AVI4 | |
| AWPGFQRLQEQLRAA | 41 | Q9H497 | |
| RGLNWLISLYENGIN | 186 | O60264 | |
| RNVLLAFSWRNPDIG | 736 | Q9UPU7 | |
| PNAQFITRSWLRDGL | 476 | P56192 | |
| PRLAWYLDGQLQEAS | 61 | Q86YD3 | |
| NILQASGNFYIWRPL | 36 | Q8IWR1 | |
| LWRYTGTRPSNLANN | 331 | Q9HAW7 | |
| EQRRNYQPRWRGEYL | 576 | C9JLR9 | |
| YLINPNGEVQWRRAL | 571 | Q9BRZ2 | |
| YLQPQLDWQARGRGE | 76 | Q6ICL3 | |
| LWRYTGTRPSNLANN | 331 | Q9HAW9 | |
| WVVNREYLSPNQLSR | 671 | Q15349 | |
| DLSYNNLRQVPWAGI | 151 | Q6PJG9 | |
| WDFLRRSQQAGFLLP | 341 | Q6IA69 | |
| TNRGYRAAEWQLDQP | 26 | Q9NVZ3 |